Beximco Pharmaceuticals Limited - GDR - Reg S BXP
Dividend Summary
The previous Beximco Pharmaceuticals Limited - GDR - Reg S dividend was 3.18c and it went ex 1 year ago and it was paid 10 months ago.
There is typically 1 dividend per year (excluding specials).
Summary | Previous dividend | Next dividend |
---|---|---|
Status | Paid | – |
Type | Final | – |
Per share | 2.52p (3.18c) | – |
Declaration date | 20 Oct 2023 (Fri) | – |
Ex-div date | 10 Nov 2023 (Fri) | – |
Pay date | 08 Feb 2024 (Thu) | – |
Enter the number of Beximco Pharmaceuticals Limited - GDR - Reg S shares you hold and we'll calculate your dividend payments:
Sign up for Beximco Pharmaceuticals Limited - GDR - Reg S and we'll email you the dividend information when they declare.
Add Beximco Pharmaceuticals Limited - GDR - Reg S to receive free notifications when they declare their dividends.
Your account is set up to receive Beximco Pharmaceuticals Limited - GDR - Reg S notifications.
Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
---|---|---|---|---|---|---|---|---|
Forecast | Final | – | 15 Nov 2027 | – | USD | Sign up | — | |
Forecast | Final | – | 18 Nov 2026 | – | USD | Sign up | — | |
Forecast | Final | – | 21 Nov 2025 | – | USD | Sign up | — | |
Declared | Final | 29 Oct 2024 | 22 Nov 2024 | – | USD | 3.35c | 3.35c | 😄 |
Paid | Final | 20 Oct 2023 | 10 Nov 2023 | 08 Feb 2024 | USD | 3.18c | 3.18c | 😄 |
Paid | Final | 28 Oct 2022 | 17 Nov 2022 | 19 Jan 2023 | USD | 3.45c | 3.32c | 😃 |
Paid | Final | 21 Oct 2021 | 18 Nov 2021 | 15 Feb 2022 | USD | 2.09c | 3.97c | 😖 |
Paid | Final | 29 Oct 2020 | 23 Nov 2020 | 27 Jan 2021 | USD | — | 1.77c | |
Paid | Final | 29 Oct 2019 | 21 Nov 2019 | 04 Feb 2020 | USD | — | 1.77c | |
Paid | Final | 02 Nov 2018 | 22 Nov 2018 | 20 Jan 2019 | USD | — | 1.49c | |
Paid | Final | – | 13 Nov 2017 | 22 Feb 2018 | USD | — | 1.5c | |
Paid | Final | 12 Oct 2016 | 28 Oct 2016 | 28 Dec 2016 | USD | — | 0.63c | |
Paid | Final | 04 May 2015 | 19 May 2015 | 29 Jun 2015 | USD | — | 1.28c | |
Paid | Final | 05 May 2014 | 14 May 2014 | 29 Jul 2014 | USD | — | 1.28c |
Year | Amount | Change |
---|---|---|
2006 | 0.0p | — |
2007 | 0.0p | 0% |
2008 | 0.0p | 0% |
2009 | 0.0p | 0% |
2010 | 0.0p | 0% |
2011 | 0.0p | 0% |
2012 | 0.0p | 0% |
2013 | 0.755412p | 100% |
2014 | 0.813726p | 7.7% |
2015 | 0.0p | -100.0% |
2016 | 0.515315p | 100% |
2017 | 1.077741p | 109.1% |
2018 | 1.147628p | 6.5% |
2019 | 1.35744p | 18.3% |
2020 | 1.290374p | -4.9% |
2021 | 2.931837p | 127.2% |
2022 | 2.681431p | -8.5% |
2023 | 2.519976p | -6.0% |
2024 | Sign Up Required | |
2025 | Sign Up Required | |
2026 | Sign Up Required | |
2027 | Sign Up Required |
Beximco Pharmaceuticals Limited Optimized Dividend Chart
- Dividend Yield Today
- 7.4%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 15.9% on 11 September 2024
- 52 Week Low
- 6.2% on 14 December 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United Kingdom
- Share Price
- £0.36 (yesterday's closing price)
- Shares in Issue
- 91 million
- Market Cap
- £33mn
- 1
- Market Indices
- none